|
| 2,1,3-Benzoxadiazol-4-amine, N-[2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]ethyl]-N-methyl-7-nitro- Basic information |
Product Name: | 2,1,3-Benzoxadiazol-4-amine, N-[2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]ethyl]-N-methyl-7-nitro- | Synonyms: | FLTX1;N-(7-Nitrobenzo[c][1,2,5]oxadiazol-4-
yl)demethyltamoxife;N-(7-Nitrobenzo[c][1,2,5]oxadiazol-4-yl)demethyltamoxifen;2,1,3-Benzoxadiazol-4-amine, N-[2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]ethyl]-N-methyl-7-nitro-;cancer,Estrogen Receptor/ERR,FLTX1,FLTX 1,Inhibitor,fluorescent,Tamoxifen,antiestrogenic,inhibit,non-permeabilized,receptor,breast,FLTX-1,estrogen,permeabilized,uterus;CB38231393 | CAS: | 1481401-71-1 | MF: | C31H28N4O4 | MW: | 520.58 | EINECS: | | Product Categories: | | Mol File: | 1481401-71-1.mol | ![2,1,3-Benzoxadiazol-4-amine, N-[2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]ethyl]-N-methyl-7-nitro- Structure](CAS/20200611/GIF/1481401-71-1.gif) |
| 2,1,3-Benzoxadiazol-4-amine, N-[2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]ethyl]-N-methyl-7-nitro- Chemical Properties |
Boiling point | 679.5±65.0 °C(Predicted) | density | 1.258±0.06 g/cm3(Predicted) | solubility | DMSO : 25 mg/mL (48.02 mM; Need ultrasonic) | pka | -3.81±0.50(Predicted) | form | Solid | color | Orange to red |
| 2,1,3-Benzoxadiazol-4-amine, N-[2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]ethyl]-N-methyl-7-nitro- Usage And Synthesis |
| 2,1,3-Benzoxadiazol-4-amine, N-[2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]ethyl]-N-methyl-7-nitro- Preparation Products And Raw materials |
|